|
|
Name: |
BAKER BROS ADVISORS LLC |
City: |
NEW YORK |
State: |
NY |
Zip: |
10021 |
|
|
|
Achive
data |
View
Filing Period: |
|
|
|
|
|
|
Download |
|
|
|
|
|
Free Registration Required For Full Results
|
|
|
Holdings
Found :
15 |
|
View All Holdings |
Currently
Viewing:
Increased Positions |
|
|
Page 1 of 1 |
Menu
|
Ticker |
Company Name |
Position Rank |
New/Closed Postion |
Last Close |
Value |
Shares Held |
% of Portfolio |
Value Change |
Change In Shares Held |
% of Company |
Industry |
|
INCY |
Incyte Corp |
1 |
- |
$58.20 |
$2,061,156,000 |
36,179,665 |
25.86% |
-210,531,000 |
543 |
16.52 |
Biotechnology |
|
RVMD |
Revolution Medicines, Inc. |
6 |
- |
$39.77 |
$243,312,000 |
7,549,249 |
3.05% |
95,649,000 |
2,400,592 |
4.609 |
N/A |
|
ABCL |
Abcellera Biologics Inc. |
8 |
- |
$0.00 |
$124,691,000 |
27,525,640 |
1.56% |
-6,124,000 |
4,615,887 |
10.225 |
N/A |
|
BCYC |
Bicycle Therapeutics Ltd |
9 |
- |
$0.00 |
$123,076,000 |
4,942,823 |
1.54% |
90,706,000 |
3,152,433 |
13.104 |
N/A |
|
EWTX |
Edgewise Therapeutics, Inc. |
10 |
- |
$0.00 |
$106,523,000 |
5,840,059 |
1.34% |
72,469,000 |
2,727,273 |
6.329 |
N/A |
|
DNLI |
Denali Therapeutics Inc. |
15 |
- |
$20.06 |
$76,574,000 |
3,731,695 |
0.96% |
20,624,000 |
1,124,499 |
3.112 |
N/A |
|
AKRO |
Akero Therapeutics, Inc. |
17 |
- |
$0.00 |
$68,536,000 |
2,713,205 |
0.86% |
13,234,000 |
344,827 |
4.427 |
N/A |
|
IMTX |
Immatics N.V |
19 |
- |
$10.34 |
$67,720,000 |
6,443,398 |
0.85% |
6,237,000 |
604,545 |
10.242 |
N/A |
|
STOK |
Stoke Therapeutics, Inc. |
29 |
- |
$0.00 |
$45,474,000 |
3,368,443 |
0.57% |
34,795,000 |
1,338,309 |
7.078 |
N/A |
|
IGMS |
Igm Biosciences, Inc. |
31 |
- |
$0.00 |
$39,452,000 |
4,088,322 |
0.49% |
8,780,000 |
397,311 |
16.88 |
N/A |
|
CELC |
Celcuity Inc. |
34 |
- |
$15.99 |
$33,534,000 |
1,552,478 |
0.42% |
25,732,000 |
1,017,000 |
7.164 |
N/A |
|
SANA |
Sana Biotechnology, Inc. |
37 |
- |
$0.00 |
$23,809,000 |
2,380,949 |
0.3% |
15,649,000 |
380,949 |
1.27 |
N/A |
|
NGNE |
Neurogene |
38 |
- |
$3.68 |
$23,211,000 |
456,015 |
0.29% |
14,422,000 |
2,499 |
1.089 |
N/A |
|
XNCR |
Xencor Inc |
45 |
- |
$24.50 |
$12,070,000 |
545,431 |
0.15% |
6,859,000 |
300,000 |
0.822 |
Biotechnology |
|
DSGN |
Design Therapeutics, Inc. |
59 |
- |
$0.00 |
$6,698,000 |
1,662,120 |
0.08% |
2,723,000 |
162,120 |
2.988 |
N/A |
|